TCBIO
Get informed when a big investor buys or sells
+ FollowUndervalued by 860.4% based on the discounted cash flow analysis.
| Market cap | $4.31 Billion |
|---|---|
| Enterprise Value | $-27,471,944,776.00 |
| Dividend Yield | $1.44 (0.40%) |
| Earnings per Share | $6.87 |
| Beta | 0.67 |
| Outstanding Shares | 45,021,962 |
| P/E Ratio | 12.84 |
|---|---|
| PEG | 130.25 |
| Price to Sales | 0.48 |
| Price to Book Ratio | 0.24 |
| Enterprise Value to Revenue | -14.69 |
| Enterprise Value to EBIT | -74.36 |
| Enterprise Value to Net Income | -79 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -7.7 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data